STXBP1 rs886043572: Understanding This Rare Genetic Variant
The rs886043572 variant is a rare genetic mutation located within the STXBP1 gene. It is clinically associated with early infantile epileptic encephalopathy, a condition characterized by severe seizures and developmental delays.
What each genotype means
Typical STXBP1 function
This genotype represents the common, non-variant sequence for this position in the STXBP1 gene. It is not associated with the pathogenic effects described for the variant, and individuals with this genotype do not carry the specific mutation linked to early infantile epileptic encephalopathy 9.
This is the most common genotype found in the general population.
Pathogenic variant carrier
This genotype indicates the presence of the c.1651C>T (p.Arg551Cys) mutation, which is classified as pathogenic. Research indicates this variant disrupts the STXBP1 protein, and it is strongly associated with early infantile epileptic encephalopathy 9. Please discuss these findings with a medical geneticist or your clinician to understand the clinical implications for your specific health context.
This variant is extremely rare and is typically identified as a de novo mutation, meaning it is generally not inherited from parents.
Pathogenic variant homozygous
This genotype indicates that both copies of the gene carry the c.1651C>T mutation. Given the severe nature of STXBP1-related encephalopathy, this finding is clinically significant and requires professional medical evaluation. Please consult with a specialist to discuss the implications of this result.
This genotype is not observed in standard population databases and is considered exceptionally rare.
What is the rs886043572 Variant?
The rs886043572 variant is a specific genetic alteration identified within the STXBP1 gene. In genomics, an rsID (reference SNP cluster ID) like rs886043572 serves as a unique identifier for a specific location in the human genome where a variation has been observed. This particular variant is categorized as a pathogenic mutation, meaning it is linked to a known disease process. Because it is rare, it is not typically found in the general population and is often identified through clinical genetic testing in individuals presenting with specific neurological symptoms. Understanding this variant requires looking at its position within the STXBP1 gene, which provides the instructions for building a protein essential for brain function. When a variant like this occurs, it can disrupt the normal production or function of that protein, leading to the clinical manifestations observed in affected individuals.
The Role of the STXBP1 Gene
The STXBP1 gene, sometimes referred to as Munc18-1, plays a critical role in the communication between neurons in the brain. It encodes a protein that is essential for the release of neurotransmitters, the chemical messengers that allow brain cells to send signals to one another. When the STXBP1 gene is functioning correctly, it ensures that these signals are transmitted efficiently, supporting normal cognitive and motor development. However, when a pathogenic variant occurs, it can lead to a loss of function, meaning the body does not produce enough of the protein or the protein produced does not work as intended. This disruption in neuronal communication is the underlying mechanism for STXBP1-related disorders, which can manifest as epilepsy, intellectual disability, and other developmental differences. Research into this gene is ongoing, with scientists exploring how different types of mutations impact the severity of the resulting clinical symptoms.
Research and Clinical Associations
Scientific research has established a strong link between pathogenic variants in the STXBP1 gene and a group of conditions known as developmental and epileptic encephalopathies (DEE). Specifically, rs886043572 is associated with early infantile epileptic encephalopathy, a severe form of epilepsy that typically begins in the neonatal period or early infancy. Studies indicate that clinical severity often correlates with the biophysical impact of the variant on the Munc18-1 protein. While some variants may lead to milder epilepsy syndromes, others, including many truncating or severe missense mutations, are associated with profound neurodevelopmental impairment and refractory seizures. Current research is focused on understanding these genotype-phenotype correlations to better predict clinical outcomes. It is important to note that while the association between this gene and DEE is well-documented, the clinical presentation can vary significantly between individuals, even those with similar genetic findings.
Population Frequency and Clinical Context
The rs886043572 variant is considered rare, and it is not a common polymorphism found in the general population. STXBP1-related disorders as a whole are estimated to have an incidence rate of approximately 1 in 30,000, though some estimates suggest it may affect up to 1 in 26,000 children globally. Because these variants are often de novo—meaning they occur spontaneously in the individual rather than being inherited from parents—they are not typically tracked as common variants in large-scale population databases. The rarity of this specific variant means that data regarding its frequency across different ancestral groups is limited. For families or individuals who have received a report identifying this variant, it is essential to consult with a clinical geneticist or a neurologist. These professionals can provide context based on the individual's specific clinical history and help navigate the complexities of genetic testing results.
Navigating Genetic Information
Genetic information regarding variants like rs886043572 is intended for educational and clinical purposes. If you or a family member have been identified as a carrier of this variant, it is vital to work closely with a healthcare team, including neurologists and genetic counselors. This information cannot be used to self-diagnose or determine treatment plans. Currently, there are no approved gene-specific therapies for STXBP1-related disorders, though research into gene replacement and other therapeutic strategies is actively underway in preclinical models. Readers should be aware that genetic testing results are complex and should always be interpreted in the context of a physical examination and clinical assessment. Never make changes to medications or medical management based on genetic reports without direct guidance from a qualified clinician. Genetic counseling can provide support in understanding the implications of these findings for the individual and their family.
How common is this variant?
The rs886043572 variant is rare, with no significant frequency in the general population as it is typically a de novo mutation associated with clinical cases.
Frequently asked questions
What is the STXBP1 gene?
The STXBP1 gene provides instructions for making a protein called Munc18-1, which is essential for brain cells to communicate with each other. Mutations in this gene can disrupt this communication, leading to epilepsy and developmental delays.
Is rs886043572 inherited?
Most pathogenic variants in the STXBP1 gene are de novo, meaning they occur spontaneously in the affected individual and are not inherited from the parents. Genetic testing of parents can help determine if the variant is de novo or inherited.
Are there treatments for STXBP1-related disorders?
Currently, there are no approved gene-specific treatments for STXBP1-related disorders. Management typically focuses on controlling seizures and providing supportive care for developmental needs, under the guidance of a medical specialist.
Where can I find more information about my genetic report?
If you have a genetic report, the best course of action is to schedule an appointment with a genetic counselor or your primary healthcare provider. They can explain the findings in the context of your specific health history.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs886043572?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29